INR 655.0
(14.25%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue | 776.36 Million | 614.46 Million | 668.3 Million | - |
Cost of Revenue | 720.26 Million | 291.12 Million | 554.22 Million | - |
Gross Profit | 56.1 Million | 323.33 Million | 114.07 Million | - |
Operating Expenses | 62.5 Million | 85.77 Million | 82.21 Million | 4000.00 |
Selling, General and Administrative Expenses | 37.76 Million | 25.96 Million | 30.19 Million | 4000.00 |
Research and Development Expenses | - | - | - | - |
Other Expenses | 64.65 Million | 8.3 Million | 8.87 Million | - |
Cost and Expenses | 782.76 Million | 376.9 Million | 636.43 Million | 4000.00 |
Operating Income | - | 240.1 Million | 35.93 Million | -4000.00 |
Interest Expense | 4.72 Million | 16.42 Million | - | - |
Income Tax Expense | -6 Million | 77.17 Million | 25.43 Million | - |
Earnings before Tax | 4.87 Million | 320.51 Million | 94.97 Million | -4000.00 |
Net Income | 10.88 Million | 243.34 Million | 69.53 Million | -4000.00 |
Earnings Per Share Basic | 2.52 | 56.29 | 16.09 | -0.08 |
Earnings Per Share Diluted | 2.52 | 56.29 | 16.09 | -0.08 |
Weighted Average Shares Outstanding | 4.32 Million | 4.32 Million | 4.32 Million | 50 Thousand |
Weighted Average Shares Outstanding (Diluted) | 4.32 Million | 4.32 Million | 4.32 Million | 50 Thousand |
Gross Margin | 0.07 | 0.53 | 0.17 | - |
EBIT Margin | 0.02 | 0.41 | 0.08 | - |
Profit Margin | 0.01 | 0.40 | 0.10 | - |
EBITDA | 14.51 Million | 338.68 Million | 96.91 Million | -4000.00 |
Earnings Before Tax Margin | - | 0.39 | 0.05 | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 4.07 Million | 123.84 Million | 601.37 Million | 776.36 Million | 123.79 Million | 44.62 Million |
Cost of Revenue | 2.74 Million | 176.95 Million | 548.73 Million | 720.26 Million | 102.01 Million | 34.98 Million |
Gross Profit | 1.32 Million | -53.11 Million | 52.64 Million | 56.1 Million | 21.78 Million | 9.63 Million |
Operating Expenses | 32.95 Million | 16.01 Million | 17.8 Million | 62.5 Million | 29.96 Million | 23.01 Million |
Selling, General and Administrative Expenses | 20.06 Million | 16.01 Million | 17.8 Million | - | 17.34 Million | 11.99 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 32.95 Million | 3.07 Million | 6.61 Million | 15.99 Million | 3 Million | 3.12 Million |
Cost and Expenses | 35.69 Million | 192.97 Million | 566.54 Million | 782.76 Million | 131.97 Million | 58 Million |
Operating Income | -31.62 Million | -69.12 Million | 34.83 Million | -6.39 Million | -8.17 Million | -13.37 Million |
Interest Expense | 6.63 Million | 1.58 Million | 1.08 Million | 4.72 Million | 904 Thousand | 853 Thousand |
Income Tax Expense | 3.27 Million | - | -6 Million | -6 Million | 3 Million | 3.12 Million |
Earnings before Tax | -34.97 Million | -67.63 Million | 40.36 Million | 4.87 Million | -6.07 Million | -11.11 Million |
Net Income | -34.97 Million | -67.63 Million | 46.37 Million | 10.88 Million | -6.07 Million | -11.11 Million |
Earnings Per Share Basic | -8.09 | -15.65 | 10.75 | - | -1.41 | -2.57 |
Earnings Per Share Diluted | -8.09 | -15.65 | 10.75 | - | -1.41 | -2.57 |
Weighted Average Shares Outstanding | 4.32 Million | 4.32 Million | 4.31 Million | 4.32 Million | 4.3 Million | 4.32 Million |
Weighted Average Shares Outstanding (Diluted) | 4.32 Million | 4.32 Million | 4.31 Million | 4.32 Million | 4.3 Million | 4.32 Million |
Gross Margin | 0.33 | -0.43 | 0.09 | 0.07 | 0.18 | 0.22 |
EBIT Margin | -6.47 | -0.54 | 0.06 | - | -0.03 | -0.19 |
Profit Margin | -8.59 | -0.55 | 0.08 | 0.01 | -0.05 | -0.25 |
EBITDA | -26.34 Million | -67.13 Million | 36.82 Million | - | -3.19 Million | -8.31 Million |
Earnings Before Tax Margin | -7.77 | -0.56 | 0.06 | -0.01 | -0.07 | -0.30 |
MANG
ARTEMISMED
3199
AMRT
ALLGO
DMCC